INDSWIFT LABORATORIES
Back to Income Statement
|
INDSWIFT LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,281 Cr | ₹1,207 Cr | ₹1,039 Cr | ₹891 Cr | ₹780 Cr |
What is the latest Revenue of INDSWIFT LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,281 Cr |
| Mar2024 | ₹1,207 Cr |
| Mar2023 | ₹1,039 Cr |
| Mar2022 | ₹891 Cr |
| Mar2021 | ₹780 Cr |
How is Revenue of INDSWIFT LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,281 Cr | 6.10 | |
| Mar2024 | ₹1,207 Cr | 16.23 | |
| Mar2023 | ₹1,039 Cr | 16.54 | |
| Mar2022 | ₹891 Cr | 14.33 | |
| Mar2021 | ₹780 Cr | - | |
Compare Revenue of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹1,928.8 Cr | 9.1% | 41.7% | 95.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 9.1% |
41.7% |
95.7% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses